The job cuts are part of the drugmaker’s plan to boost profitability after its $63 million acquisition of Monsanto.
Job cuts in Germany are potentially costly because of tight labor protections, according to the report.
A Bayer spokesperson declined Bloomberg‘s request for comment on the layoffs.
The 12,000 job cuts will be completed by the end of 2021.
More articles on pharmacy:
PBM hearing should prompt bill to ban ‘secrecy’ in drug industry, senator says
Republicans tell drugmakers that complying with House probe could hurt their stock prices
Hawaii primary care network opens in-house pharmacy
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.